RHY 0.00% 4.7¢ rhythm biosciences limited

CSIRO National Library of Medicine article from 2015, page-2

  1. 541 Posts.
    lightbulb Created with Sketch. 74
    This excellent analysis needs bumping. Read a few independent peer-reviewed research articles that indicated colostat could actually be poised to replace FIT based on study 6 alone

    Also another CSIRO piece indicating NZ inadequate bowel screening program that only commenced in 2017 with GPS seldom recommending a FIT test even though it’s the biggest point of call for primary health
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.